LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
What is the latest Profit After Tax of LINCOLN PHARMACEUTICALS ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹93 Cr |
Mar2023 | ₹73 Cr |
Mar2022 | ₹69 Cr |
Mar2021 | ₹62 Cr |
Mar2020 | ₹51 Cr |
How is Profit After Tax of LINCOLN PHARMACEUTICALS Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹93 Cr | 27.99 | |
Mar2023 | ₹73 Cr | 5.11 | |
Mar2022 | ₹69 Cr | 11.41 | |
Mar2021 | ₹62 Cr | 20.95 | |
Mar2020 | ₹51 Cr | - |
Compare Profit After Tax of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,043.4 Cr | -6.8% | -30.4% | -15.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -6.8% |
-30.4% |
-15.7% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses